Immunophenotyping in Myelodysplastic Syndromes Can Add Prognostic Information to Well-Established and New Clinical Scores

BACKGROUND: myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic clonal disorders. So, prognostic variables are important to separate patients with a similar biology and clinical outcome. We compared the importance of risk stratification in primary MDS of IPSS and WPSS with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis-Alves, Suiellen C., Traina, Fabíola, Harada, Guilherme, Campos, Paula M., Saad, Sara T. O., Metze, Konradin, Lorand-Metze, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855682/
https://www.ncbi.nlm.nih.gov/pubmed/24324660
http://dx.doi.org/10.1371/journal.pone.0081048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855682/
https://www.ncbi.nlm.nih.gov/pubmed/24324660
http://dx.doi.org/10.1371/journal.pone.0081048

Ejemplares similares